Enliven Therapeutics
ELVNInsider trades and stock quote 2024-2026
All insider trades at Enliven Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/10/2026 | Sell | Collins, Helen Louise | CHIEF MEDICAL OFFICER | $30.2 | $305,827 |
| 3/9/2026 | Sell | Collins, Helen Louise | CHIEF MEDICAL OFFICER | $30.0 | $896,811 |
| 3/6/2026 | Sell | Hohl, Benjamin | CHIEF FINANCIAL OFFICER | $29.6 | $295,839 |
| 2/17/2026 | Sell | Heyman, Richard A. | Director | $26.2 | $32,196 |
| 2/17/2026 | Sell | Collins, Helen Louise | CHIEF MEDICAL OFFICER | $26.2 | $1,177,862 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)